*Based on a clinical study conducted with 36 volunteers by an independent lab in September 2025 Aqua, 3-O- Ethyl ascorbic acid, Propanediol, Propylene glycol, Betaine, Glycerin, Glyceryl Glucoside, Glutathione, Phenoxyethanol, Squalane, Sodium Acrylates Copolymer, Lecithin, Undecylenoyl Phenylalanine, Allantoin, Tocopherol, Carbomer, Ethylhexylglycerin, Octenidine HCl, Disodium EDTA, Triethanolamine, Allergen free fragrance Aqua, 3-O- Ethyl ascorbic acid, Propanediol, Propylene glycol, Betaine, Glycerin, Glyceryl Glucoside, Glutathione, Phenoxyethanol, Squalane, Sodium Acrylates Copolymer, Lecithin, Undecylenoyl Phenylalanine, Allantoin, Tocopherol, Carbomer, Ethylhexylglycerin, Octenidine HCl, Disodium EDTA, Triethanolamine, Allergen free fragrance Vegan Paraben Free Dermatologically Tested Cruelty Free Sulfate Free Users see visible brightening and reduced dark spots within 2-3 weeks of consistent daily use
TB-500: ~4963 g/mol PubChem CID : BPC-157: 9941957
Patients can select a local NC retail pharmacy, a mail-order pharmacy, or a compounding pharmacy depending on their cost and product preferences
Ojima A, Ishibashi Y, Matsui T, Maeda S, Nishino Y, Takeuchi M et al
Research and development expenses totaled $2.1 million, down 66% from $6.4 million, reflecting the completion of GLP-1 agonist trials, including the Phase Ib GLP-1-H24-4 study
While compelling, a lack of clinical evidence has left researchers skeptical of Akkermansias efficacy, warning that more studies are needed